Cargando…
Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
Autores principales: | Moon, Jeonghyeon, Lee, Seon-yeong, Choi, Jeong Won, Lee, A. Ram, Yoo, Jin Hee, Moon, Su-Jin, Park, Sung-Hwan, Cho, Mi-La |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218406/ https://www.ncbi.nlm.nih.gov/pubmed/34154617 http://dx.doi.org/10.1186/s12967-021-02916-0 |
Ejemplares similares
-
Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
por: Moon, Jeonghyeon, et al.
Publicado: (2021) -
Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation
por: Moon, Jeonghyeon, et al.
Publicado: (2022) -
Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance
por: Lee, Seon-Yeong, et al.
Publicado: (2015) -
GRIM-19 Ameliorates Multiple Sclerosis in a Mouse Model of Experimental Autoimmune Encephalomyelitis with Reciprocal Regulation of IFNγ/Th1 and IL-17A/Th17 Cells
por: Moon, Jeonghyeon, et al.
Publicado: (2020) -
Brown adipose tissue ameliorates autoimmune arthritis via inhibition of Th17 cells
por: Moon, Jeonghyeon, et al.
Publicado: (2020)